ACQUIRED · 2024
Who Acquired Vantive Kidney Care (Baxter)?
Carlyle · $3.80B
The acquisition
Vantive Kidney Care (Baxter) was acquired by Carlyle in 2024 for $3.80B. at 0.80× revenue.
Vantive Kidney Care (Baxter) at time of acquisition
Revenue
$4513.0M
Deal value
$3.80B
Other acquisitions by Carlyle
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- Psychiatric Medical Care · 2025 · $400.0M · 20.0× EBITDA
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from SEC filings and press releases. Full deal page.
Citation: ExitValue.ai. (2024). Vantive Kidney Care (Baxter) acquired by Carlyle. https://exitvalue.ai/acquired/vantive-kidney-care-baxter